QQQ   290.05 (-0.12%)
AAPL   112.74 (-0.97%)
MSFT   209.33 (-0.37%)
FB   270.24 (+0.67%)
GOOGL   1,735.80 (+0.48%)
AMZN   3,104.26 (+0.19%)
TSLA   534.11 (+2.35%)
NVDA   517.51 (-1.54%)
BABA   274.31 (+1.55%)
CGC   27.08 (+9.55%)
GE   10.57 (+4.97%)
MU   63.08 (-1.71%)
AMD   83.82 (-1.75%)
T   29.15 (+1.85%)
NIO   53.33 (-3.70%)
F   9.23 (+4.18%)
ACB   8.93 (+24.37%)
NFLX   478.10 (+0.31%)
GILD   60.06 (+0.28%)
BA   218.42 (+3.26%)
DIS   149.41 (+2.35%)
QQQ   290.05 (-0.12%)
AAPL   112.74 (-0.97%)
MSFT   209.33 (-0.37%)
FB   270.24 (+0.67%)
GOOGL   1,735.80 (+0.48%)
AMZN   3,104.26 (+0.19%)
TSLA   534.11 (+2.35%)
NVDA   517.51 (-1.54%)
BABA   274.31 (+1.55%)
CGC   27.08 (+9.55%)
GE   10.57 (+4.97%)
MU   63.08 (-1.71%)
AMD   83.82 (-1.75%)
T   29.15 (+1.85%)
NIO   53.33 (-3.70%)
F   9.23 (+4.18%)
ACB   8.93 (+24.37%)
NFLX   478.10 (+0.31%)
GILD   60.06 (+0.28%)
BA   218.42 (+3.26%)
DIS   149.41 (+2.35%)
QQQ   290.05 (-0.12%)
AAPL   112.74 (-0.97%)
MSFT   209.33 (-0.37%)
FB   270.24 (+0.67%)
GOOGL   1,735.80 (+0.48%)
AMZN   3,104.26 (+0.19%)
TSLA   534.11 (+2.35%)
NVDA   517.51 (-1.54%)
BABA   274.31 (+1.55%)
CGC   27.08 (+9.55%)
GE   10.57 (+4.97%)
MU   63.08 (-1.71%)
AMD   83.82 (-1.75%)
T   29.15 (+1.85%)
NIO   53.33 (-3.70%)
F   9.23 (+4.18%)
ACB   8.93 (+24.37%)
NFLX   478.10 (+0.31%)
GILD   60.06 (+0.28%)
BA   218.42 (+3.26%)
DIS   149.41 (+2.35%)
QQQ   290.05 (-0.12%)
AAPL   112.74 (-0.97%)
MSFT   209.33 (-0.37%)
FB   270.24 (+0.67%)
GOOGL   1,735.80 (+0.48%)
AMZN   3,104.26 (+0.19%)
TSLA   534.11 (+2.35%)
NVDA   517.51 (-1.54%)
BABA   274.31 (+1.55%)
CGC   27.08 (+9.55%)
GE   10.57 (+4.97%)
MU   63.08 (-1.71%)
AMD   83.82 (-1.75%)
T   29.15 (+1.85%)
NIO   53.33 (-3.70%)
F   9.23 (+4.18%)
ACB   8.93 (+24.37%)
NFLX   478.10 (+0.31%)
GILD   60.06 (+0.28%)
BA   218.42 (+3.26%)
DIS   149.41 (+2.35%)
Log in
NASDAQ:REPH

Recro Pharma Short Interest Ratio and Short Volume

$2.02
+0.04 (+2.02 %)
(As of 11/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.97
Now: $2.02
$2.08
50-Day Range
$1.51
MA: $1.93
$2.34
52-Week Range
$1.49
Now: $2.02
$19.21
Volume427,367 shs
Average Volume405,704 shs
Market Capitalization$47.76 million
P/E Ratio10.10
Dividend YieldN/A
Beta0.61

Short Interest

Recro Pharma (NASDAQ:REPH) Short Interest Data

Current Short Volume:913,800 shares
Previous Short Volume:651,600 shares
Change Vs. Previous Month:+40.24%
Dollar Volume Sold Short:$1.72 million
Short Interest Ratio / Days to Cover:3.0
Last Record Date:October, 30 2020
Outstanding Shares:22,180,000 shares
Float Size:20,030,000 shares
Short Percent of Float:4.56%
Today's Trading Volume:427,367 shares
Average Trading Volume:405,704 shares
Today's Volume Vs. Average:5.34%



Recro Pharma (NASDAQ:REPH) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
10/30/2020913,800 $1.72 million 40.2%4.6%3.1$1.88
10/15/2020651,600 $1.21 million 13.3%3.3%2.1$1.85
9/30/2020574,900 $1.33 million -10.1%2.9%1.8$2.31
9/15/2020639,200 $1.33 million -15.0%3.2%1.9$2.08
8/31/2020751,600 $1.64 million 5.3%3.8%2$2.18
8/14/2020713,600 $1.98 million 7.5%3.6%1.8$2.77
7/31/2020663,800 $2.04 million 1.2%3.3%1.1$3.08
7/15/2020656,000 $2.68 million -31.9%3.3%1.2$4.09
6/30/2020963,000 $4.00 million 2.4%4.8%1.7$4.15
6/15/2020940,900 $4.43 million 8.4%4.7%1.6$4.71
5/29/2020868,000 $4.10 million -27.7%4.4%1.5$4.72
5/15/20201,200,000 $5.42 million -2.4%6.0%2$4.52
4/30/20201,230,000 $5.95 million 5.1%6.2%2.5$4.84
4/15/20201,170,000 $5.94 million 34.5%5.9%3$5.08
3/31/2020869,900 $7.05 million -40.5%4.4%2.2$8.11
3/13/20201,461,300 $12.93 million 19.8%7.4%2$8.85
2/28/20201,220,000 $8.67 million -1.6%6.2%3.3$7.11
2/14/20201,240,000 $11.77 million 39.7%6.5%4$9.49
1/31/2020887,600 $13.62 million -18.6%4.6%2.7$15.34
1/15/20201,090,000 $19.28 million -15.5%5.7%3.2$17.69
12/31/20191,290,000 $20.49 million 20.6%6.7%3.9$15.88

Recro Pharma (NASDAQ:REPH) Short Interest FAQ

speech bubbles
speech bubbles











What is Recro Pharma's current short interest?

Short interest is the volume of Recro Pharma shares that have been sold short but have not yet been closed out or covered. As of October 30th, traders have sold 913,800 shares of REPH short. 4.56% of Recro Pharma's shares are currently sold short. View details.

What is a good short interest ratio for Recro Pharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Recro Pharma currently has a short interest ratio of 3.0.

What is a good short interest percentage for Recro Pharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.56% of Recro Pharma's floating shares are currently sold short.

Is Recro Pharma's short interest increasing or decreasing?

Recro Pharma saw a increase in short interest in October. As of October 30th, there was short interest totaling 913,800 shares, an increase of 40.2% from the previous total of 651,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Recro Pharma's float size?

Recro Pharma currently has issued a total of 23,645,000 shares. Some of Recro Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Recro Pharma currently has a public float of 20,030,000 shares.

How does Recro Pharma's short interest compare to its competitors?

4.56% of Recro Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Recro Pharma: Aptevo Therapeutics Inc. (3.02%), Alpine Immune Sciences, Inc. (0.26%), NeuBase Therapeutics, Inc. (0.00%), Strongbridge Biopharma plc (1.48%), BELLUS Health Inc. (1.32%), Cassava Sciences, Inc. (0.00%), Assembly Biosciences, Inc. (0.00%), Theratechnologies Inc. (2.27%), Eton Pharmaceuticals, Inc. (5.81%), and Cerecor Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.66 billion), Aon Plc ($3.83 billion), Analog Devices, Inc. ($3.33 billion), ViacomCBS Inc. ($3.13 billion), Snap Inc. ($3.05 billion), The Clorox Company ($2.85 billion), Uber Technologies, Inc. ($2.80 billion), Moderna, Inc. ($2.26 billion), Simon Property Group, Inc. ($2.02 billion), and International Flavors & Fragrances Inc. ($1.96 billion). View all of the most shorted stocks.

What does it mean to sell short Recro Pharma stock?

Short selling REPH is an investing strategy that aims to generate trading profit from Recro Pharma as its price is falling. Recro Pharma's stock is trading up $0.04 today. To short Recro Pharma stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Recro Pharma will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Recro Pharma?

A short squeeze for Recro Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of REPH, which in turn drives the price of the stock up even further.

How often is Recro Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REPH, twice per month. The most recent reporting period available is October, 30 2020.


This page was last updated on 11/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.